Fluid Therapy Guidelines Contributors
![Dog with iv receiving fluid therapy](https://www.aaha.org/wp-content/uploads/2024/06/dog-with-iv-receiving-fluid-therapy.png)
Mariana Pardo, BVSc, MV, DACVECC✝
Critical Care Veterinarian Consulting, Pleasantville, New York
Erin Spencer, MEd, CVT, VTS (ECC)✝
Veterinary Emergency Group, Derry, New Hampshire
Adesola Odunayo, DVM, MS, DACVECC
University of Florida, Gainesville, Florida
Mary L. Ramirez, DVM, DABVP (Canine and Feline)
North Dallas Veterinary Emergency and Specialty Hospital, Frisco, Texas
Elke Rudloff, DVM, DACVECC, cVMA
Blue Pearl Pet Hospice, Milwaukee, Wisconsin
Heidi Shafford, DVM, PhD, DACVAA
Veterinary Anesthesia Specialists, Gladstone, Oregon
Ann Weil, DVM, MS, DACVAA
Purdue University, West Lafayette, Indiana
Ewan Wolff, DVM, PhD, DACVIM (Small Animal Internal Medicine)
Blue Pearl NE Portland, Portland, Oregon
Contributing Reviewers
Elisa Mazzaferro, MS, DVM, PhD, DACVECC
Cornell University Veterinary Specialists, Department of Emergency and Critical Care
Vaidehi Paranjape, BVSc, MVSc, MS, DACVAA
Virginia Polytechnic Institute and State University, Virginia-Maryland College of Veterinary Medicine, Department of Small Animal Clinical Sciences
✝ M. Pardo and E. Spencer are the cochairs of the AAHA Fluid Therapy Guidelines Task Force.
These guidelines were prepared by a task force of experts convened by the American Animal Hospital Association. This document is intended as a guideline only, not an AAHA standard of care. These guidelines and recommendations should not be construed as dictating an exclusive protocol, course of treatment, or procedure. Variations in practice may be warranted based on the needs of the individual patient, resources, and limitations unique to each individual practice setting. Evidence-guided support for specific recommendations has been cited whenever possible and appropriate. Other recommendations are based on practical clinical experience and a consensus of expert opinion. Further research is needed to document some of these recommendations. Drug approvals and labeling are current at the time of writing but may change over time. Because each case is different, veterinarians must base their decisions on the best available scientific evidence in conjunction with their own knowledge and experience.
AAHA gratefully acknowledges the task force facilitator, Mia Cary, DVM (she/her), of Cary Consulting, and Theresa Entriken, DVM, for developmental editing assistance.
AAHA welcomes endorsement of these Guidelines by the American Association of Feline Practitioners (AAFP).